Mesoblast (MESO) Other Non Operating Income (2016 - 2025)

Mesoblast (MESO) posted quarterly Other Non Operating Income of $10.3 million for Q4 2025, up 596.67% on a QoQ basis from $1.5 million in Q4 2023.

Mesoblast (MESO) Other Non Operating Income (2016 - 2025) Analysis & Trends

Mesoblast (MESO) has reported Other Non Operating Income for 9 consecutive years, with $10.3 million the latest figure, recorded in Q4 2025.

  • Quarterly Other Non Operating Income changed N/A year-over-year to $10.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.3 million (changed N/A YoY) and the FY2022 annual result came in at $5.9 million, up 486.88% from the prior year.
  • Other Non Operating Income improved to $10.3 million in Q4 2025 per MESO's latest filing, from $1.5 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for MESO reached as high as $10.3 million in Q4 2025 and fell as low as -$401000.0 in Q3 2022.
  • A 4-year average of $2.5 million and a median of $1.5 million in 2022 frame the typical range for Other Non Operating Income.
  • The largest YoY upside for Other Non Operating Income was 138.05% in 2021 against a maximum downside of 185.54% in 2021.
  • Year by year, Other Non Operating Income stood at $2.2 million in 2021, then sank by 31.55% to $1.5 million in 2022, then changed by 0.0% to $1.5 million in 2023, then soared by 596.67% to $10.3 million in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $10.3 million, $1.5 million, and $1.5 million for Q4 2025, Q4 2023, and Q1 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Mesoblast 2.08 Bn 1.95 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 10.26 Mn
Dec 31, 2023 1.47 Mn
Mar 31, 2023 1.47 Mn
Dec 31, 2022 1.47 Mn
Sep 30, 2022 -401,000.00
Jun 30, 2022 5.89 Mn
Mar 31, 2022 896,000.00
Dec 31, 2021 2.15 Mn
Sep 30, 2021 -349,000.00
Dec 31, 2020 904,000.00
Sep 30, 2020 408,000.00
Jun 30, 2019 -33,000.00
Sep 30, 2018 -23,000.00
Jun 30, 2018 -334,000.00
Sep 30, 2017 -358,000.00
Jun 30, 2017 -52,000.00
Jun 30, 2016 -381,000.00